ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Recursos principais

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
AI Entrar Premium IconPremium Help Menu
Índice Bovespa
133.324,96
0,24%
S&P 500
5.752,92
0,13%
US Dollar vs BRL
5,43715
-0,02%
Bitcoin
66.249,89
1,64%
Brent Oil
71,355
0,57%
Registration Strip Icon for pro Negocie como um profissional: Aproveite discussões em tempo real e ideias que movimentam o mercado para superar a concorrência.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Aptose Biosciences Inc (APTO)

  7. Aptose Biosciences Inc (APTO) Notícias

APTO

Aptose Biosciences (APTO)

Aptose Biosciences Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:APTO
DataHoraFonteTítuloCódigoCompanhia
06/09/202417:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:APTOAptose Biosciences Inc
05/09/202417:15GlobeNewswire Inc.Aptose Announces Results from Special Meeting of ShareholdersNASDAQ:APTOAptose Biosciences Inc
30/08/202417:30GlobeNewswire Inc.Aptose Receives $10 Million Through a Facility Agreement with Hanmi; Negotiating Future Collaboration Agreement with Hanmi to Jointly Develop TuspetinibNASDAQ:APTOAptose Biosciences Inc
15/08/202417:30GlobeNewswire Inc.Aptose Announces Adjournment of its Special Meeting of ShareholdersNASDAQ:APTOAptose Biosciences Inc
08/08/202418:22Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:APTOAptose Biosciences Inc
08/08/202418:06GlobeNewswire Inc.Aptose Reports Results for the Second Quarter 2024NASDAQ:APTOAptose Biosciences Inc
19/07/202418:00GlobeNewswire Inc.Aptose Announces Receipt of Deficiency Notice from NasdaqNASDAQ:APTOAptose Biosciences Inc
17/07/202412:43Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:APTOAptose Biosciences Inc
03/06/202407:05Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:APTOAptose Biosciences Inc
10/05/202412:35Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:APTOAptose Biosciences Inc
14/02/202418:51Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:APTOAptose Biosciences Inc
26/01/202419:30Edgar (US Regulatory)Form 424B4 - Prospectus [Rule 424(b)(4)]NASDAQ:APTOAptose Biosciences Inc
26/01/202402:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:APTOAptose Biosciences Inc
25/01/202423:44Edgar (US Regulatory)Form S-1MEF - Registration adding securities to prior Form S-1 registration [Rule 462(b)]NASDAQ:APTOAptose Biosciences Inc
19/01/202423:50Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:APTOAptose Biosciences Inc
21/09/202318:10Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:APTOAptose Biosciences Inc
06/07/202317:01Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:APTOAptose Biosciences Inc
26/06/202317:11Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:APTOAptose Biosciences Inc
20/06/202307:01Edgar (US Regulatory)Securities Registration Statement (s-1)NASDAQ:APTOAptose Biosciences Inc
19/04/202307:02Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:APTOAptose Biosciences Inc
03/04/202317:23Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:APTOAptose Biosciences Inc
24/03/202307:01Edgar (US Regulatory)Annual Report (10-k)NASDAQ:APTOAptose Biosciences Inc
14/02/202319:19Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:APTOAptose Biosciences Inc
17/01/202308:08Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:APTOAptose Biosciences Inc
12/12/202213:55TipRanksJonesTrading Keeps Their Buy Rating on Aptose Biosciences (APTO)NASDAQ:APTOAptose Biosciences Inc
17/11/202211:55TipRanksAptose Biosciences (APTO) Gets a Buy from H.C. WainwrightNASDAQ:APTOAptose Biosciences Inc
02/11/202208:45TipRanksJonesTrading Remains a Buy on Aptose Biosciences (APTO)NASDAQ:APTOAptose Biosciences Inc
02/11/202207:15TipRanksH.C. Wainwright Reaffirms Their Buy Rating on Aptose Biosciences (APTO)NASDAQ:APTOAptose Biosciences Inc
01/11/202217:17Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:APTOAptose Biosciences Inc
24/10/202207:05Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:APTOAptose Biosciences Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:APTO

Seu Histórico Recente

NASDAQI
SX4510PI
OMX Stockholm Food, Beve...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados